← 返回

3D 生物打印在肿瘤免疫逃逸建模中的前景

英文原题:Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion.

查看英文原题

Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion.

PubMed 2022/06/26(内容时间) Cancers (Basel) Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

在活体内,癌细胞处于特定微环境中,会与其他细胞及周围细胞外基质(ECM)交换大量物理和生化信号。免疫逃逸具有重要临床意义,指癌细胞能够将这些信号交换导向对抗免疫效应细胞,并形成有利于自身生存的免疫抑制环境。充分理解这一现象对于开发更有效的抗癌疗法至关重要。然而,传统细胞培养系统难以充分再现肿瘤微环境(TME)的动态特性与复杂性,因而不适于全面研究肿瘤免疫逃逸机制。相比之下,3D生物打印是一种快速发展的制造技术,可构建细节精密、由多种细胞类型及模拟ECM的生物材料组成的结构。本综述聚焦当前使用的3D生物打印技术及其在TME研究中的应用,并探讨其在肿瘤免疫逃逸建模和免疫治疗反应研究中的潜在用途。

展开英文摘要原文

In a living organism, cancer cells function in a specific microenvironment, where they exchange numerous physical and biochemical cues with other cells and the surrounding extracellular matrix (ECM). Immune evasion is a clinically relevant phenomenon, in which cancer cells are able to direct this interchange of signals against the immune effector cells and to generate an immunosuppressive environment favoring their own survival. A proper understanding of this phenomenon is substantial for generating more successful anticancer therapies.

However, classical cell culture systems are unable to sufficiently recapture the dynamic nature and complexity of the tumor microenvironment (TME) to be of satisfactory use for comprehensive studies on mechanisms of tumor immune evasion.

In turn, 3D-bioprinting is a rapidly evolving manufacture technique, in which it is possible to generate finely detailed structures comprised of multiple cell types and biomaterials serving as ECM-analogues. In this review, we focus on currently used 3D-bioprinting techniques, their applications in the TME research, and potential uses of 3D-bioprinting in modeling of tumor immune evasion and response to immunotherapies.

论文信息

作者
Staros R、Michalak A、Rusinek K、Mucha K、Pojda Z、Zagożdżon R
单位
Department of Immunology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-006 Warsaw, Poland.Poland
文献类型
综述
期刊
Cancers2022 Jun 26
原文标识
PubMed 35804898 · DOI 10.3390/cancers14133126